← European Medicine Shortage Tracker · all medicines

Lamivudine shortage — availability across Europe

Lamivudine currently has availability issues reported in 2 European registers: France, Italy.

MEDICALLY REVIEWED

Dr. Chrysoula I. Liakou MD, PhD

Internal Medicine Specialist
Cancer Immunology Researcher

Reviewed 30 July 2026 · next review due 30 January 2027

Shortage ATC — · also listed as: lamivudine · LAMIVUDINA · data refreshed 7 August 2026

Key facts

As of 7 August 2026, Lamivudine has active availability issues in 2 of 10 tracked European registers.
Registers reporting issues: France, Italy.
Longest-running open report: since 2025-09-11 (11 months, Italy).
Data source: 2 official medicines-agency registers, refreshed daily.

As of 7 August 2026, 2 of the 10 tracked registers list current availability issues for Lamivudine, covering 3 affected product presentations. The longest-running open report was filed in Italy on 2025-09-11 and has now been open for about 11 months. Where agencies state a cause, manufacturing problems lead with 2 of the 2 stated-cause reports. Registers in Italy indicate that alternatives or equivalents are available — a pharmacist or doctor can advise on switching.

Where	Status & products	Since	Expected end	Reason / alternatives	Source
🇫🇷 France	Limited availability Zeffix 5 mg/ml, solution buvable	—	—	Infectiologie	register ↗
🇮🇹 Italy	Shortage LAMIVUDINA AUROBINDO ITALIA + 1 more products LAMIVUDINA MYLAN PHARMA	2025-09-11	—	Elevata richiesta/problemi produttivi Alternatives: AIFA: equivalents with the same active substance are available.	register ↗

New register reports per month

Full report history (3 register entries)

Every individual register entry for Lamivudine in the tracked sources, newest first — including resolved and discontinued reports.

Reg.	Product	Status	Reported	Expected end	Stated reason
🇮🇹 IT	LAMIVUDINA MYLAN PHARMA	Shortage	2026-07-07	—	Problemi produttivi
🇮🇹 IT	LAMIVUDINA AUROBINDO ITALIA	Shortage	2025-09-11	—	Elevata richiesta/problemi produttivi
🇫🇷 FR	Zeffix 5 mg/ml, solution buvable	Limited availability	—	—	Infectiologie

Frequently asked

Is Lamivudine currently in shortage in Europe?

Yes. As of 7 August 2026, availability issues are reported in: France, Italy. Availability is national — a shortage in one country does not mean it is short everywhere.

Are there alternatives to Lamivudine?

2 of the active register entries indicate alternatives or equivalents (same active substance or an alternative treatment). Do not switch on your own — a pharmacist or prescriber can confirm the right substitute in your country.

Where does this Lamivudine availability data come from?

Directly from the official medicines-agency registers that list Lamivudine: ANSM (France), AIFA (Italy). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.

Embed this tracker

Pharmacies, patient sites and newsrooms are welcome to embed the live status of Lamivudine — free, with attribution. Copy this snippet:

<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/lamivudine/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Lamivudine availability in Europe"></iframe>
<p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/lamivudine/">Lamivudine shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>

Cite: “Lamivudine: availability status across 2 European registers — European Medicine Shortage Tracker (MobiDoctor), 7 August 2026.” Link this page and the agency record. Statuses come from the linked official registers and can change daily.